The molecular diagnostics industry is a relatively new territory that offers much promise for early disease detection and personalized patient care. When analyzing samples at the molecular level, there are serious consequences for errors, and tests must be highly accurate and precise. For example, molecular diagnostics may be used to detect the presence of DNA in samples collected at a crime scene, or to determine whether parents carry a genetic mutation that causes inherited diseases, such as cystic fibrosis.

While quality molecular test results are essential, standardized quality control materials for molecular diagnostic tests were rare until recently, when Maine Molecular Quality Control Inc. (MMQCI) was founded to fill this market need. The company manufactures and sells the first FDA-approved quality control materials for genetic testing and is on a mission to help companies that use or manufacture molecular diagnostics enhance their data integrity.

Quality is the company’s mantra and MMQCI practices what it preaches. As pipetting is one of the most ubiquitous and important processes in the development and manufacture of its quality control materials, MMQCI has a stringent liquid handling quality assurance program.

 …